Research Roundup: What we’re reading this week
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Kayla Laserson, director of the Centers for Disease Control and Prevention/Kenya Medical Research Institute Field Research Station in Kenya, writes about why US support for global health research is so critical.
Investigators gave more detail about the positive results from the Partners PrEP Study at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle this week. The study found that antiretroviral treatment can prevent HIV transmission in couples where one partner is HIV-positive and the other is HIV-negative.
Brazil’s National Health Surveillance Agency recently granted registration of a new child-friendly dosage of benznidazole, a treatment for Chagas disease. The dosage was developed through a partnership between the Pernambuco State Pharmaceutical Laboratory of Brazil and the Drugs for Neglected Diseases initiative.
The University of Dundee has received funding from the Wellcome Trust and pharmaceutical company GlaxoSmithKline to research some of the world's neglected tropical diseases, including Chagas disease and African sleeping sickness.